hNPC-01

N/A

Report date: 2026/02/27 13:56:48

Base Information

Drug NamehNPC-01
Drug Alias Name人前脑神经前体细胞注射液hNPC-01
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsIschemic StrokeHemiplegiaStroke +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhejiang Huode Bioengineering Company Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesZhejiang Huode Bioengineering Company Ltd
Inactive CompaniesN/A
Active IndicationsIschemic StrokeHemiplegiaStroke +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A